JAN 07, 2017 08:28 AM PST

How a Native Indian Pepper Suppresses Cancer

WRITTEN BY: Xuan Pham

Peppers are in the spotlight again this week as scientists reveal the biological mechanism behind the anticancer effects of a different compound from an Indian pepper plant, known as the long pepper.

Earlier this week, I reported on capsaicin – the spicy chemical in chili peppers – and how this was reported to be effective against some breast cancer subtypes. Rather than capsaicin, researchers found that a chemical in the Indian long pepper (Piper longum), known as piperlongumine (PL), acts to silence a gene that’s overly abundant in cancers.

In some cell experiments, PL killed some types of cancer cells while leaving healthy cells alone. In a mouse xenograft model, PL was shown to be effective at stopping cancer spread. Combined, PL has demonstrated anticancer effects in prostate, breast, lung, colon, lymphoma, leukemia, primary brain tumors, and gastric cancer.

The link between the long pepper and anticancer effects are not new – the medicinal properties and potential of this plant dates back thousands of years in the Ayurveda texts. The plant was also noted in the records from Hippocrates who is well-regarded as the father of medicine.

To shed light o the anecdotal anticancer effects of the long pepper, scientists at the University of Texas, Southwestern investigated the structural and biochemical properties of piperlongumine (PL). Using x-ray crystallography – a technique that reveals the atomic and molecular structure of compounds – the team analyzed what happens to PL after it enters the body.

They showed after hydrolysis of PL, the product (hPL) binds at the active site GSTP1 (Glutathione S-transferase pi 1) – a protein that’s overexpressed in cancerous tumors. Binding of hPL at GSTP1’s active site essentially inhibits this protein and may thereby block cancer proliferation.

"We are hopeful that our structure will enable additional drug development efforts to improve the potency of PL for use in a wide range of cancer therapies," said Kenneth Westover, a professor at UT Southwestern, and the study’s senior author. "This research is a spectacular demonstration of the power of x-ray crystallography."

Moreover, the results provide a biological mechanism for what’s been suspected for thousands of years. "This study illustrates the importance of examining and re-examining our theories. In this case we learned something fundamentally new about a 3,000-year-old medical claim using modern science," said Dr. Westover.

The team hopes that in uncovering the x-ray crystal structure of the compound and how it interacts with cancer proteins, further research could lead to new and more effective drug targets. 

Additional sources: UT Southwestern Medical Center

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 06, 2019
Drug Discovery & Development
DEC 06, 2019
Insulin Drug Could Treat Glioblastoma
A molecule used for drug delivery of insulin was recently found by researchers at the University of Georgia’s Regenerative Bioscience Center to hold...
DEC 06, 2019
Cancer
DEC 06, 2019
Handheld device detects skin cancer
I can’t be the only one who has ever looked at a suspicious freckle and wondered, “Could this be skin cancer?” Of course, when 9,500 Amer...
DEC 06, 2019
Cancer
DEC 06, 2019
Electronic "nose" sniffs out the best cancer treatment
Can you imagine an electronic device that is capable of figuring out which lung cancer patients will respond best to immunotherapy? If so, now try to imagi...
DEC 06, 2019
Drug Discovery & Development
DEC 06, 2019
Compound in Daffodils Can Help Fight Cancer
Preventing the growth of tumors presents a challenge for scientists in finding a cure to cancer. Now however, researchers from the University Libre de Brux...
DEC 06, 2019
Cancer
DEC 06, 2019
Looking to the depths of the human genome to understand cancer
Have you ever heard of dark matter? No, I’m not talking about the dark matter of the universe – I mean the dark matter that lives within your g...
DEC 06, 2019
Drug Discovery & Development
DEC 06, 2019
The Side-Effects to A Common Blood Cancer Drug
In a study published in Scientific Reports, a popular cancer drug, known as ruxolitnib, was found to cause an increased weight gain as well as an increase ...
Loading Comments...